Moderna hits five-year high on sales beat and raised guidance
FROM THE WIRE · FINANCE.YAHOO.COM
Moderna stock surged to a five-year high Friday on the back of its Street-walloping vaccine sales and guidance hike for the year. Continue Reading
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishSales above estimates and a raised guidance push the stock to multi-year highs.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01The stock hit a five-year high on Friday.
- 02Vaccine sales beat Street estimates.
- 03The company raised its full-year guidance.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets